{
    "nct_id": "NCT06232577",
    "official_title": "5x-Multiplier vs 3-Tier Model for Discharge Opioid Prescriptions After Intra-abdominal Cancer Surgery: A Randomized Clinical Trial",
    "inclusion_criteria": "* Participants â‰¥18 years of age\n* Participants undergoing any of the following abdominal surgeries on an elective basis at MD Anderson Cancer Center:\n* Open pancreatectomy\n* Open hepatectomy\n* Open resection of retroperitoneal sarcoma\n* Open nephrectomy\n* Open cytoreductive surgery (in ovarian cancer)\n* Participants with a planned inpatient admission of at least 48 hours after surgery\n* Opioid-naive patients who use less than or equal to 7.5 mg OME per day (on average) during the 30 days prior to consent\n* Participants able to understand and willing to sign an informed consent document\n* English and non-English-speaking participants\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Participants requiring non-elective (emergent or urgent) surgery will be excluded\n* Participants with a current or previous history of substance abuse disorder, including alcohol or drugs\n* Participants prescribed long-acting chronic pain medications\n* Participants using hydromorphone or fentanyl or under the care of a chronic pain specialist\n* Participants unable or unwilling to participate in follow-up study requirements (e.g., QOL surveys, opioid log)\n* Participants discharged on palliative or hospice care\n* Participants with a history of allergic reactions to opioids\n* Participants enrolled in any other opioid discharge protocol\n* Participants who are pregnant\n* Participants who are cognitively impaired",
    "miscellaneous_criteria": ""
}